CELH
Celsius Holdings, Inc.
CELH has the edge over PEP overall, supported by stronger modeled upside and stronger fundamentals.
PEP
PepsiCo, Inc.
PEP has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PEP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Unavailable | |
| Stable |
PEP's profitability is currently strong, and its revenue and balance sheet are stable. There isn't enough data to rate its cash flow.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
PEP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $142 | — |
| Cheap | 22x | $177 | +24% |
| Fair | 26x | $209 | +47% |
| Expensive | 28x | $226 | +59% |
Historical ranges are pointers, not guarantees.
PEP has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
PEP Forward outlook
There aren't enough analyst estimates for PEP to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
PEP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $7.96 | +51% |
| Q2 2026 | $7.63 | +39% |
| Q1 2026 | $6.37 | -6.3% |
| Q4 2025 | $6.00 | -14% |
| Q3 2025 | $5.26 | -22% |
| Q2 2025 | $5.49 | -20% |
| Q1 2025 | $6.80 | +2.4% |
| Q4 2024 | $6.95 | +5.9% |
PEP has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over PEP on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over PEP on profitability, with a higher operating margin.
PEP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25.3B | +5.6% |
| Q2 2026 | $24.2B | +6.4% |
| Q1 2026 | $19.4B | +8.5% |
| Q4 2025 | $29.3B | +5.6% |
| Q3 2025 | $23.9B | +2.7% |
| Q2 2025 | $22.7B | +1% |
| Q1 2025 | $17.9B | -1.8% |
| Q4 2024 | $27.8B | -0.2% |
PEP's revenue has grown year over year for six quarters in a row: $25.3B last quarter, up 5.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +1.9 points |
| Q2 2026 | 17% | +8.8 points |
| Q1 2026 | 17% | +2.1 points |
| Q4 2025 | 12% | +4 points |
| Q3 2025 | 15% | -1.7 points |
| Q2 2025 | 7.9% | -10 points |
| Q1 2025 | 14% | -0.5 points |
| Q4 2024 | 8.1% | +2.1 points |
PEP's operating margin was 17% last quarter, up 1.9 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
PEP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.5B | +41% |
| Q1 2026 | -$406M | +$1.2B |
| Q3 2025 | $3.5B | -7.3% |
| Q2 2025 | $1.1B | -16% |
| Q1 2025 | -$1.6B | +$79M |
| Q2 2024 | $1.3B | -14% |
| Q1 2024 | -$1.7B | -$682M |
| Q2 2023 | $1.5B | +37% |
PEP still generates free cash flow, though less than at its 2020 peak: $5.6B over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over PEP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
PEP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -2M shares |
| 1 year | -0.4% | -5M shares |
| 3 years | -1.2% | -16M shares |
| 5 years | -1.6% | -22M shares |
| Available history | -2.8% | -40M shares |
PEP has 1.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $297M |
| Q1 2026 | $182M |
| Q3 2025 | $258M |
| Q2 2025 | $311M |
| Q1 2025 | $183M |
| Q3 2024 | $299M |
| Q2 2024 | $315M |
| Q1 2024 | $146M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over PEP on leverage, with a lower net debt burden relative to earnings.
PEP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.5x | Moderate |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 2.7x | Moderate |
PEP's net debt is about 2.5 years of its operating earnings (EBITDA).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
PEP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.1 | Neutral |
| Stochastic | 75.1 | Neutral |
PEP's weekly RSI is 54 (neutral) and its Stochastic is 75 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
PEP PE vs Consumer Defensive Sector
| Metric | PEP | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 19x | 8.3% below |
| PE % | 5 | 18 | 13 pts below |
PEP has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
PEP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $133.6 | 6.5% above |
| 20 week MA | $136.6 | 4.2% above |
| 50 week MA | $145.8 | 2.5% below |
| 100 week MA | $144.7 | 1.7% below |
| 200 week MA | $159.0 | 11% below |
PEP has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 11% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
PEP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $137.5 | $145.1 | +5.5% |
| 2021 | $145.1 | $169.8 | +17% |
| 2022 | $169.8 | $182.3 | +7.4% |
| 2023 | $182.3 | $169.8 | -6.8% |
| 2024 | $169.8 | $152.9 | -10% |
| 2025 | $152.9 | $143.8 | -6% |
| 2026 YTD | $143.8 | $142.3 | -1.1% |
PEP has the edge over CELH on returns for 2026, with the stronger performance.